oral GCS inhibitor

Preclinical, neurodegeneration

scaffold hop from prev. reported GCS inhibitor

J. Med. Chem.

Takeda

oral GCS inhibitor - Takeda

Context. T-690 (Takeda) is an oral GCS inhibitor that is brain-penetrant, non-basic, and non-competitive with UDP-glucose. We recently highlighted a glucosylceramide synthase (GCS, aka CGT) inhibitor in Ph. III…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: